$AAQL
Antiaging Quantum Living Inc.

2023 Q2 Form 10-Q Financial Statement

#000149315223029478 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q2
Revenue $1.200K $2.400K
YoY Change -50.0% 33.33%
Cost Of Revenue $0.00
YoY Change
Gross Profit $1.200K $2.400K
YoY Change -50.0% 33.33%
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin $23.51K
YoY Change 45.03%
% of Gross Profit 979.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $78.00 $79.00
YoY Change -1.27%
% of Gross Profit 6.5% 3.29%
Operating Expenses $30.93K $23.51K
YoY Change 31.58% 44.99%
Operating Profit -$29.73K -$21.11K
YoY Change 40.85% 46.45%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$29.73K -$21.11K
YoY Change 40.85% 55.89%
Income Tax
% Of Pretax Income
Net Earnings -$29.73K -$21.11K
YoY Change 40.85% 55.89%
Net Earnings / Revenue -2477.25% -879.38%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 -$703.80
COMMON SHARES
Basic Shares Outstanding 30.00M shares 30.00M shares 30.00M shares
Diluted Shares Outstanding 30.00M shares 30.00M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.440K
YoY Change 11.63%
Cash & Equivalents $34.32K $354.00 $1.439K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $738.00
Receivables
Other Receivables
Total Short-Term Assets $35.06K $354.00 $1.439K
YoY Change 2336.55% -97.52% -97.29%
LONG-TERM ASSETS
Property, Plant & Equipment $462.00 $540.00 $775.00
YoY Change -40.39% -36.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $462.00 $540.00 $775.00
YoY Change -40.39% -36.77%
TOTAL ASSETS
Total Short-Term Assets $35.06K $354.00 $1.439K
Total Long-Term Assets $462.00 $540.00 $775.00
Total Assets $35.52K $894.00 $2.214K
YoY Change 1504.52% -94.09% -95.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $901.00
YoY Change
Accrued Expenses $4.302K $901.00 $8.596K
YoY Change -49.95%
Deferred Revenue $1.600K $2.800K $3.200K
YoY Change -50.0% -50.0%
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due $61.00K
YoY Change
Total Short-Term Liabilities $68.06K $87.00K $72.80K
YoY Change -6.51% 34.68% 0.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $68.06K $87.00K $72.80K
Total Long-Term Liabilities $0.00
Total Liabilities $68.06K $87.00K $72.80K
YoY Change -6.51% 34.68% 0.27%
SHAREHOLDERS EQUITY
Retained Earnings -$306.1K -$276.3K -$260.8K
YoY Change 17.35% 15.28%
Common Stock $30.00K $30.00K $30.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$32.53K -$86.11K -$70.58K
YoY Change
Total Liabilities & Shareholders Equity $35.52K $894.00 $2.214K
YoY Change 1504.52% -94.09% -95.82%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q2
OPERATING ACTIVITIES
Net Income -$29.73K -$21.11K
YoY Change 40.85% 55.89%
Depreciation, Depletion And Amortization $78.00 $79.00
YoY Change -1.27%
Cash From Operating Activities -$28.19K -$14.83K
YoY Change 90.06% -8.52%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $62.16K $2.000K
YoY Change 3007.8%
NET CHANGE
Cash From Operating Activities -$28.19K -$14.83K
Cash From Investing Activities
Cash From Financing Activities $62.16K $2.000K
Net Change In Cash $33.97K -$12.83K
YoY Change -364.77% -20.86%
FREE CASH FLOW
Cash From Operating Activities -$28.19K -$14.83K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 ACHN Related Party Debt Forgiven As Additional Paidin Capital
RelatedPartyDebtForgivenAsAdditionalPaidinCapital
usd
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001672571
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q2 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://achison.com/20230630#ShareholdersMember
CY2023Q1 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://achison.com/20230630#ShareholdersMember
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 dei Entity File Number
EntityFileNumber
000-56157
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
Antiaging Quantum Living Inc.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2643986
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
133-27 39th Ave
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Ths #PH2A
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Flushing
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11354
CY2023Q2 dei City Area Code
CityAreaCode
(929)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
527-5382
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29995000 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34324 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
354 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
738 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
35062 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
354 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
462 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
540 usd
CY2023Q2 us-gaap Assets
Assets
35524 usd
CY2023Q1 us-gaap Assets
Assets
894 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4302 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
901 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
62156 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
83300 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1600 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2800 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
68058 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
87001 usd
CY2023Q2 us-gaap Liabilities
Liabilities
68058 usd
CY2023Q1 us-gaap Liabilities
Liabilities
87001 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
243530 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160230 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-306059 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-276332 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-32534 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-86107 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35524 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
894 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1200 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2400 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1200 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
2400 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30927 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23505 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
30927 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
23505 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-29727 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-21105 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29727 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21105 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29727 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21105 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29995000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29995000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.001
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.001
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-86107 usd
CY2023Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
83300 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29727 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-32534 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49477 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21105 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-70582 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29727 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21105 usd
CY2023Q2 us-gaap Depreciation
Depreciation
78 usd
CY2022Q2 us-gaap Depreciation
Depreciation
79 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
738 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3401 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8596 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1200 usd
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2400 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28186 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14830 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
62156 usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
62156 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33970 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12830 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
354 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14269 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34324 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1439 usd
CY2023Q2 ACHN Related Party Debt Forgiven As Additional Paidin Capital
RelatedPartyDebtForgivenAsAdditionalPaidinCapital
83300 usd
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023Q2 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-12-29
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zChGwdLoUiv" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zMwtbEqusjg">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-306059 usd
CY2023Q2 ACHN Working Capital
WorkingCapital
-32996 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1600 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2800 usd
CY2023Q2 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Net operation losses (“NOLs”) can be carried forever based on the 2017 Tax Cuts and Jobs Act
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
54000 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
69000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares

Files In Submission

Name View Source Status
0001493152-23-029478-index-headers.html Edgar Link pending
0001493152-23-029478-index.html Edgar Link pending
0001493152-23-029478.txt Edgar Link pending
0001493152-23-029478-xbrl.zip Edgar Link pending
achn-20230630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
achn-20230630_pre.xml Edgar Link unprocessable
achn-20230630_def.xml Edgar Link unprocessable
achn-20230630_lab.xml Edgar Link unprocessable
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
achn-20230630_cal.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed